SCHEMBL6232308

SCHEMBL6232308

COc1ccc(CC2SC(=O)NC2=O)cc1C(=O)CCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.56
PPARA Q07869 6/20 0.56
PTPN1 P18031 2/20 0.52
FFAR1 O14842 3/20 0.47
CA2 P00918 1/20 0.46
MPC2 O95563 1/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALDH1A1 P00352 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PPARD Q03181 2/20 0.41
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20125593 0.84 PPARA (0.61) PPARGPPARAPTPN1PPARD
SCHEMBL29358494 0.84 PPARA (0.61) PPARGPPARAPTPN1PPARD
SCHEMBL3922 0.84 PPARA (0.61) PPARGPPARAPTPN1PPARD
SCHEMBL4055559 0.84 PPARG (0.54) PPARGPPARAPTPN1FFAR1CA2
SCHEMBL14379043 0.84 PPARA (0.61) PPARGPPARAPTPN1PPARD
SCHEMBL8981746 0.80 PPARA (0.54) PPARGPPARAPTPN1FFAR1PPARD
SCHEMBL8981743 0.80 PPARA (0.54) PPARGPPARAPTPN1FFAR1PPARD
SCHEMBL5707014 0.79 PTPN1 (0.64) PPARGPPARAPTPN1FFAR1CA2
SCHEMBL6498084 0.79 FFAR1 (0.56) PPARGPPARAPTPN1FFAR1CA2
SCHEMBL6497355 0.78 PPARG (0.54) PPARGPPARAPTPN1FFAR1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213287-B1 SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DIONE DERIVATIVES KYORIN SEIYAKU KK (JP) 2005-05-25 EP claimed
US-6730687-B1 THERAPY OF METABOLIC DISEASES SUCH AS DIABETES AND HYPERLIPIDEMIA AS AGONISTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR KYORIN PHARMACEUTICAL CO., LTD. (JP) 2004-05-04 US claimed
EP-1213287-A1 SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DIONE DERIVATIVES KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP claimed
EP-1213287-B1 SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DIONE DERIVATIVES KYORIN SEIYAKU KK (JP) 2005-05-25 EP disclosed
US-6730687-B1 THERAPY OF METABOLIC DISEASES SUCH AS DIABETES AND HYPERLIPIDEMIA AS AGONISTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR KYORIN PHARMACEUTICAL CO., LTD. (JP) 2004-05-04 US disclosed
EP-1213287-A1 SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DIONE DERIVATIVES KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed